Glutathione-Dependent Pathways in Cancer Cells

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Glutathione (GSH), a key tripeptide, and related enzymes like glutathione peroxidases (GPxs) and glutathione S-transferases (GSTs) play vital roles in cellular processes.
• These molecules are significantly involved in regulating tumor cell viability, cancer initiation, progression, and resistance to therapies.

Purpose of the Study:

• This review discusses recent findings on GSH synthesis, the functions of GPxs and GSTs in cancer development.
• It also explores the potential of targeting GST and GPx enzymes for novel cancer treatments.

Main Methods:

• Literature review of recent scientific findings.
• Analysis of the roles and functions of GSH, GPxs, and GSTs in cancer.
• Exploration of potential therapeutic strategies targeting these molecules.

Main Results:

• Elevated GSH synthesis in cancers is linked to increased expression of γ-glutamyl cycle enzymes and altered amino acid transport.
• GPxs are essential for cellular viability by reducing hydroperoxides, with distinct roles in maintaining redox balance.
• GSTs conjugate GSH to electrophiles, reduce hydroperoxides, regulate signaling pathways, and influence cellular processes like metabolism and drug resistance through S-glutathionylation.

Conclusions:

• GSH, GPxs, and GSTs are critical regulators in cancer development, progression, and drug resistance.
• Understanding their functions provides a basis for developing targeted cancer therapies.
• The search for effective GST and GPx inhibitors is a promising avenue for cancer treatment.